Abstract:Neutralizing monoclonal antibody (mAb) therapies targeting with high specificity to SARS-CoV-2 has been considered as one of the potential therapies for COVID-19 since the beginning of the pandemic. Preclinical studies demonstrated a marked reduction in viral loads in the upper and lower respiratory tract with the use of neutralizing mAbs 1 .The mAbs have the ability to coordinate the immune defense to link to the virus and control the virus load. The mAbs are defined as an antibody derived from a single B-cel… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.